|
RPL23AP53 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.572200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.069980E-01 |
| Normal-vs-Stage2 |
1.549990E-01 |
| Normal-vs-Stage3 |
3.915900E-03 |
| Normal-vs-Stage4 |
3.760300E-02 |
| Stage1-vs-Stage2 |
8.531000E-01 |
| Stage1-vs-Stage3 |
7.906500E-02 |
| Stage1-vs-Stage4 |
4.450800E-01 |
| Stage2-vs-Stage3 |
3.302400E-01 |
| Stage2-vs-Stage4 |
6.485800E-01 |
| Stage3-vs-Stage4 |
6.371800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.307700E-02 |
| Normal-vs-AfricanAmerican |
2.438000E-01 |
| Normal-vs-Asian |
8.199000E-01 |
| Caucasian-vs-AfricanAmerican |
7.276400E-01 |
| Caucasian-vs-Asian |
1.628090E-02 |
| AfricanAmerican-vs-Asian |
2.056000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.508100E-02 |
| Normal-vs-Female |
4.378300E-02 |
| Male-vs-Female |
7.757200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.240400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.824300E-02 |
| Normal-vs-Age(61-80Yrs) |
6.882400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.439000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.666640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.198100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.760200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.521400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.086000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.123600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.552600E-01 |
| Classical-VS-Follicular |
1.483200E-03 |
| Classical-VS-Other |
2.715400E-01 |
| Classical-VS-Normal |
2.455400E-01 |
| Tall-VS-Follicular |
2.340200E-01 |
| Tall-VS-Other |
5.855400E-01 |
| Tall-VS-Normal |
8.549700E-02 |
| Follicular-VS-Other |
9.563200E-01 |
| Follicular-VS-Normal |
9.214100E-04 |
| Other-VS-Normal |
1.191220E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.377900E-03 |
| Normal-vs-N1 |
1.712210E-02 |
| N0-vs-N1 |
8.923800E-01 |
|
|
